In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach

Brett Fleisher, Sihem Ait‐Oudhia|Breast Cancer Targets and Therapy|2021

Cited by 11